Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010

Vaccine

Volumn 30, Issue 31, 2012, Pages 4676-4680

  Greenland, Katie ^a,b   Whelan, Jane ^a,b   Fanoy, Ewout ^a,c   Borgert, Marjon ^d   Hulshof, Koen ^e   Yap, Kioe Bing ^f   Swaan, Corien ^a   Donker, Tjibbe ^a   van Binnendijk, Rob ^a   de Melker, Hester ^a   Hahné, Susan ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c Municipal Health Service Midden Nederland   (Netherlands)

^d Municipal Health Service Hollands Midden   (Netherlands)

^e Municipal Health Service   (Netherlands)

^f Municipal Health Service Zuid Holland West   (Netherlands)

Author keywords

MMR vaccine; Mumps; Outbreak; Risk factors; Students; Vaccine effectiveness

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADULT; ARTICLE; BEHAVIOR; COHORT ANALYSIS; CONFIDENCE INTERVAL; DAILY LIFE ACTIVITY; DEMOGRAPHY; EPIDEMIC; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MUMPS; NETHERLANDS; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; UNIVERSITY STUDENT; VACCINATION;

ADOLESCENT; DISEASE OUTBREAKS; FEMALE; HOUSING; HUMANS; MALE; MUMPS; MUMPS VACCINE; NETHERLANDS; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIAL BEHAVIOR; STUDENTS; UNIVERSITIES; VACCINATION; YOUNG ADULT;

EID: 84861971870     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.083     Document Type: Article

References (29)

1. van Lier EA, Oomen PJ, Giesbers H, Drijfhout IH, de Hoogh PAAM, de Melker H. Vaccinatiegraad Rijksvaccinatieprogramma Nederland. Verslagjaar 2011. (National Immunisation Programme in the Netherlands. Annual Report 2011). Bilthoven: National Institute for Public Health and the Environment (RIVM). Available from: ; 2011. http://www.rivm.nl/bibliotheek/rapporten/210021014.html.
2. Brockhoff H.J., Mollema L., Sonder G.J., Postema C.A., van Binnendijk R.S., Kohl R.H. Mumps outbreak in a highly vaccinated student population, the Netherlands, 2004. Vaccine 2010, 28(17):2932-2936.
3. Karagiannis I., van Lier A., van Binnendijk R., Ruijs H., Fanoy E., Conyn-Van Spaendonck M.A., et al. Mumps in a community with low vaccination coverage in the Netherlands. Eurosurveillance 2008, 13(24.).
4. Oostvogel P.M., van Wijngaarden J.K., van der Avoort H.G., Mulders M.N., Conyn-van Spaendonck M.A., Rumke H.C., et al. Poliomyelitis outbreak in an unvaccinated community in the Netherlands: 1992-93. Lancet 1994, 344(8923):665-670.
5. Hahné S., Macey J., van Binnendijk R., Kohl R., Dolman S., van der Veen Y., et al. Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada. The Pediatric Infectious Disease Journal 2009, 28(9):795-800.
6. Rümke H.C., Visser H.K. Childhood vaccinations anno 2004. I. Effectiveness and acceptance of the Dutch National Vaccination Programme. Nederlands Tijdschrift Voor Geneeskunde 2004, 148(8):356-363.
7. Fine P., Mulholland K. Community immunity. Vaccines 2008, 1573-1592. Elsevier Inc., Philadelphia, PA, chap. 71. 5th ed. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
8. Whelan J., van Binnendijk R., Greenland K., Fanoy E., Khargi M., Yap K., et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Eurosurveillance 2010, 15(17).
9. Wharton M., Cochi S.L., Hutcheson R.H., Bistowish J.M., Schaffner W. A large outbreak of mumps in the postvaccine era. Journal of Infectious Diseases 1988, 158(6):1253-1260.
10. Kancherla V.S., Hanson I.C. Mumps resurgence in the United States. Journal of Allergy and Clinical Immunology 2006, 118(4):938-941.
11. Huang A.S., Cortese M.M., Curns A.T., Bitsko R.H., Jordan H.T., Soud F., et al. Risk factors for mumps at a university with a large mumps outbreak. Public Health Reports 2009, 124(3):419-426.
12. Whyte D., O'Dea F., McDonnell C., O'Connell N.H., Callinan S., Brosnan E., et al. Mumps epidemiology in the mid-west of Ireland 2004-2008: increasing disease burden in the university/college setting. Eurosurveillance 2009, 14(16).
13. Dayan G.H., Quinlisk M.P., Parker A.A., Barskey A.E., Harris M.L., Schwartz J.M., et al. Recent resurgence of mumps in the United States. New England Journal of Medicine 2008, 358(15):1580-1589.
14. StataCorp Statistical Software: Release 10 2008, Stata Corporation, College Station.
15. Sartwell P.E. The incubation period and the dynamics of infectious disease. American Journal of Epidemiology 1966, 83(2):204-206.
16. Update: mumps outbreak - New York and New Jersey, June 2009-January 2010. MMWR. Morbidity and Mortality Weekly Report 2010, 59(5):125-129.
17. Cortese M.M., Jordan H.T., Curns A.T., Quinlan P.A., Ens K.A., Denning P.M., et al. Mumps vaccine performance among university students during a mumps outbreak. Clinical Infectious Diseases 2008, 46(8):1172-1180.
18. Dayan G.H., Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?. Clinical Infectious Diseases 2008, 47(11):1458-1467.
19. Marin M., Quinlisk P., Shimabukuro T., Sawhney C., Brown C., Lebaron C.W. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students - Iowa, 2006. Vaccine 2008, 26(29-30):3601-3607.
20. Bernard H., Schwarz N.G., Melnic A., Bucov V., Caterinciuc N., Pebody R.G., et al. Mumps outbreak ongoing since October 2007 in the Republic of Moldova. Eurosurveillance 2008, 13(13).
21. Quinlisk M.P. Mumps control today. Journal of Infectious Diseases 2010, 202(5):655-656.
22. Watson-Creed G., Saunders A., Scott J., Lowe L., Pettipas J., Hatchette T.F. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. Canadian Medical Association Journal 2006, 175(5):483-488.
23. Dominguez A., Torner N., Castilla J., Batalla J., Godoy P., Guevara M., et al. Mumps vaccine effectiveness in highly immunized populations. Vaccine 2010, 28(20):3567-3570.
24. Rubin S.A., Qi L., Audet S.A., Sullivan B., Carbone K.M., Bellini W.J., et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. Journal of Infectious Diseases 2008, 198(4):508-515.
25. Sax L.J., Gilmartin S.K., Bryant A.N. Assessing response rates and nonresponse bias in web and paper surveys. Research in Higher Education 2003, 44(4):409-432.
26. Krosnick J.A. Survey research. Annual Review of Psychology 1999, 50:537-567.
27. Yung C.F., Andrews N., Bukasa A., Brown K.E., Ramsay M. Mumps Complications and Effects of Mumps Vaccination: England and Wales, 2002-2006. Emerging Infectious Diseases 2011, 17(4):661-667.
28. Hahné S., Whelan J., van Binnendijk R., Swaan C., Fanoy E., Boot H., et al. Mumps vaccine effectiveness against orchitis. Emerging Infectious Diseases 2012, 18(1):191-193.
29. Vandermeulen C., Leroux-Roels G., Hoppenbrouwers K. Mumps outbreaks in highly vaccinated populations: what makes good even better?. Human Vaccines 2009, 5(7):494-496.